Digoxin-like immunoreactive factors induce apoptosis in human acute T-cell lymphoblastic leukemia

被引:22
作者
Ihenetu, Kenneth
Qazzaz, Hassan M.
Crespo, Fabian
Fernandez-Botran, Rafael
Valdes, Roland, Jr.
机构
[1] Univ Louisville, Sch Med, Dept Pathol, Lab Med, Louisville, KY 40202 USA
[2] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA
关键词
D O I
10.1373/clinchem.2006.082081
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Plant-derived cardenolides reportedly possess anticancer properties in human leukemic cells via selective induction of apoptosis, cell cycle arrest, and differentiation. Selective induction of apoptosis with mammalian-derived digoxin-like immunoreactive factor (DLIF) could provide new strategies for anticancer drug development or the identification of biomarkers for cancer. We investigated whether DLIFs selectively induce apoptosis in human lymphoblastic leukemic cells. Methods: We compared the relative potencies of digoxin, ouabain, and DLIF on induction of programmed cell death in Jurkat cells (an acute T-leukemic cell line), K-562 (a myelogenous leukemia cell line), and nonpathologic human peripheral blood mononuclear cells (PBMCs). Apoptosis was measured by flow cytometry with the annexin V/propidium iodide method. Results: Digoxin and ouabain induced apoptosis in Jurkat cells [digoxin 50% inhibitory concentration (IC50), 24 nmol/L; ouabain IC50, 26 nmol/L]. Neither digoxin nor ouabain induced apoptosis in K-562 cells or PBMCs. DLIF was more potent (IC50, 1.9 nmol/L) and >2-fold more effective than digoxin or ouabain at inducing maximum apoptosis in Jurkat cells. The IC50 values in the apoptosis assays were >100-fold lower (DLIF) and 20-fold lower (digoxin and ouabain) than the IC50 required for Na+- and K+-dependent ATPase (DLIF, 200 nmol/L; digoxin, 910 nmol/L; ouabain, 600 nmol/L). Conclusion: DLIF selectively induces apoptosis in a human acute T-cell lymphoblastic leukemia cell line but not in K-562 cells or PBMCs. These data suggest a new physiological role for these endogenous hormone-like factors. (c) 2007 American Association for Clinical Chemistry.
引用
收藏
页码:1315 / 1322
页数:8
相关论文
共 40 条
[1]   Display of Fas ligand protein on cardiac vasculature as a novel means of regulating allograft rejection [J].
Akenasy, N ;
Yolcu, ES ;
Wang, ZL ;
Shirwan, H .
CIRCULATION, 2003, 107 (11) :1525-1531
[2]   Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function [J].
Blanco, G ;
Mercer, RW .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1998, 275 (05) :F633-F650
[3]  
Doris PA, 1996, MINER ELECTROL METAB, V22, P303
[4]   Targeting apoptosis pathways in cancer therapy [J].
Ghobrial, IM ;
Witzig, TE ;
Adjei, AA .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (03) :178-194
[5]   Ouabainlike compound in hypertension associated with ectopic corticotropin syndrome [J].
Goto, A ;
Yamada, K ;
Hazama, H ;
Uehara, Y ;
Atarashi, K ;
Hirata, Y ;
Kimura, K ;
Omata, M .
HYPERTENSION, 1996, 28 (03) :421-425
[6]   IDENTIFICATION AND CHARACTERIZATION OF A OUABAIN-LIKE COMPOUND FROM HUMAN PLASMA [J].
HAMLYN, JM ;
BLAUSTEIN, MP ;
BOVA, S ;
DUCHARME, DW ;
HARRIS, DW ;
MANDEL, F ;
MATHEWS, WR ;
LUDENS, JH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6259-6263
[7]  
HAUX J, 1999, Z ONKOL, V31, P14
[8]   Investigation of ouabain-induced anticancer effect in human androgen-independent prostate cancer PC-3 cells [J].
Huang, YT ;
Chueh, SC ;
Teng, CM ;
Guh, JH .
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (04) :727-733
[9]   Pharmacological characterisation of cannabinoid receptors inhibiting interleukin 2 release from human peripheral blood mononuclear cells [J].
Ihenetu, K ;
Molleman, A ;
Parsons, M ;
Whelan, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 464 (2-3) :207-215
[10]   Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells [J].
Johansson, S ;
Lindholm, P ;
Gullbo, J ;
Larsson, P ;
Bohlin, L ;
Claeson, P .
ANTI-CANCER DRUGS, 2001, 12 (05) :475-483